Raymond James Financial Services Advisors’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$10.2K Sell
11,833
-979
-8% -$848 ﹤0.01% 3392
2024
Q2
$4.59K Sell
12,812
-537
-4% -$192 ﹤0.01% 3375
2024
Q1
$8.95K Sell
13,349
-2,890
-18% -$1.94K ﹤0.01% 3360
2023
Q4
$8.82K Sell
16,239
-9,393
-37% -$5.1K ﹤0.01% 3255
2023
Q3
$15.4K Sell
25,632
-14,471
-36% -$8.68K ﹤0.01% 3180
2023
Q2
$52.1K Sell
40,103
-34,204
-46% -$44.5K ﹤0.01% 3119
2023
Q1
$131K Sell
74,307
-5,776
-7% -$10.2K ﹤0.01% 3006
2022
Q4
$251K Sell
80,083
-4,243
-5% -$13.3K ﹤0.01% 2703
2022
Q3
$413K Sell
84,326
-2,264
-3% -$11.1K ﹤0.01% 2360
2022
Q2
$358K Sell
86,590
-6,202
-7% -$25.6K ﹤0.01% 2470
2022
Q1
$539K Sell
92,792
-30,165
-25% -$175K ﹤0.01% 2334
2021
Q4
$922K Sell
122,957
-110,266
-47% -$827K ﹤0.01% 2021
2021
Q3
$2.1M Sell
233,223
-18,628
-7% -$168K ﹤0.01% 1463
2021
Q2
$3.02M Buy
251,851
+9,267
+4% +$111K 0.01% 1244
2021
Q1
$3.04M Buy
242,584
+41,743
+21% +$523K 0.01% 1161
2020
Q4
$3.13M Buy
200,841
+140,683
+234% +$2.2M 0.01% 1047
2020
Q3
$568K Sell
60,158
-3,290
-5% -$31.1K ﹤0.01% 1883
2020
Q2
$568K Buy
63,448
+17,496
+38% +$157K ﹤0.01% 1831
2020
Q1
$293K Buy
+45,952
New +$293K ﹤0.01% 1858
2019
Q4
Sell
-12,080
Closed -$109K 2877
2019
Q3
$109K Sell
12,080
-552
-4% -$4.98K ﹤0.01% 2614
2019
Q2
$136K Buy
12,632
+602
+5% +$6.48K ﹤0.01% 2623
2019
Q1
$115K Buy
12,030
+1,100
+10% +$10.5K ﹤0.01% 2617
2018
Q4
$125K Sell
10,930
-20,665
-65% -$236K ﹤0.01% 2365
2018
Q3
$536K Buy
31,595
+8,025
+34% +$136K ﹤0.01% 1853
2018
Q2
$335K Buy
23,570
+6,250
+36% +$88.8K ﹤0.01% 2160
2018
Q1
$329K Sell
17,320
-1,642
-9% -$31.2K ﹤0.01% 1978
2017
Q4
$311K Buy
18,962
+4,300
+29% +$70.5K ﹤0.01% 2000
2017
Q3
$220K Buy
+14,662
New +$220K ﹤0.01% 2211
2016
Q3
Sell
-12,783
Closed -$74K 2326
2016
Q2
$74K Buy
+12,783
New +$74K ﹤0.01% 2125